RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 125 filers reported holding RA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $785,000 | +53.3% | 35,038 | +24.6% | 0.00% | 0.0% |
Q4 2018 | $512,000 | -49.7% | 28,121 | -50.0% | 0.00% | 0.0% |
Q3 2018 | $1,018,000 | +261.0% | 56,242 | +98.6% | 0.00% | – |
Q2 2018 | $282,000 | +156.4% | 28,320 | +36.5% | 0.00% | – |
Q1 2018 | $110,000 | -37.5% | 20,744 | 0.0% | 0.00% | – |
Q4 2017 | $176,000 | -41.9% | 20,744 | 0.0% | 0.00% | – |
Q3 2017 | $303,000 | -22.1% | 20,744 | 0.0% | 0.00% | -100.0% |
Q2 2017 | $389,000 | +104.7% | 20,744 | +132.8% | 0.00% | – |
Q1 2017 | $190,000 | +40.7% | 8,910 | 0.0% | 0.00% | – |
Q4 2016 | $135,000 | – | 8,910 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |